Teva Has the Firepower for M&A Splash — Market Talk

15:43 EDT – After meeting with new TEVA CEO Erez Vigohman in recent days, JPMorgan says the drug maker aims to do deals in order to grow and has more than $5B available. The company, best known for its generic drugs, will probably do “smaller tuck-in deals” focused on generic technologies,…

Read more…